MedTrace Logo

Patients' Opinions and Responses to the National Cancer Institute's Colorectal Cancer Risk Assessment Tool

NCT01803009 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2014-04-03

No results posted yet for this study

Summary

Little is known about the impact of risk assessment tools on decision-making by patients and clinicians. In particular, even though the NCI Colorectal Cancer Risk Assessment Tool is one of the most prominent risk assessment tools available, no study has quantified its usability or impact on decision-making or uptake of screening. In this study, we will measure patients' satisfaction with the NCI CRC RAT, their perception of its usability and helpfulness, and its impact on their decision-making and behavior. In addition, we will assess the impact of adding information about their chance of having an advanced adenoma.

Conditions

Interventions

BEHAVIORAL

Patient views NCI CRC RAT

BEHAVIORAL

View presentation regarding current chance of having an advanced adenoma

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Peter H. Schwartz, MD, PhD · IU School of Medicine

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-03-31
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01803009 on ClinicalTrials.gov